sertindole has been researched along with Dyskinesia, Drug-Induced in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (70.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seeman, P; Tallerico, T | 1 |
| Buckley, PF; Daniel, DG; Kane, JM; Potkin, SG | 1 |
| Perquin, L; Steinert, T | 1 |
| Casey, DE | 1 |
| Daniel, DG; Kane, JM; Kashkin, KB; Mack, RJ; Sebree, TB; Tamminga, CA; Wallin, BA; Wozniak, PJ; Zimbroff, DL | 1 |
| Arnt, J | 1 |
| Farde, L; Halldin, C; Nilsson, U; Nyberg, S; Okubo, Y | 1 |
| Gao, XM; Sakai, K; Tamminga, CA | 1 |
| Kane, JM | 1 |
| Möller, HJ | 1 |
7 review(s) available for sertindole and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
Topics: Antipsychotic Agents; Binding, Competitive; Cholinergic Antagonists; Clozapine; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Resistance; Dyskinesia, Drug-Induced; Humans; Levodopa; Ligands; Limbic System; Nerve Tissue Proteins; Parkinson Disease, Secondary; Protein Binding; Psychoses, Substance-Induced; Psychotic Disorders; Radioligand Assay; Receptors, Dopamine D2; Receptors, Muscarinic; Receptors, Serotonin; Recurrence; Serotonin Antagonists; Tomography, Emission-Computed | 1998 |
A review of the efficacy, tolerability and safety of sertindole in clinical trials.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Cardiovascular Diseases; Clinical Trials as Topic; Cognition; Drug Tolerance; Dyskinesia, Drug-Induced; Humans; Imidazoles; Indoles; Neuropsychological Tests; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Suicide; Treatment Outcome | 2004 |
Side effect profiles of new antipsychotic agents.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Dyskinesia, Drug-Induced; Humans; Imidazoles; Indoles; Neuroleptic Malignant Syndrome; Olanzapine; Pirenzepine; Psychotic Disorders; Risperidone; Schizophrenia; Seizures; Sleep; Weight Gain | 1996 |
Pharmacological differentiation of classical and novel antipsychotics.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Brain; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Haplorhini; Humans; Imidazoles; Indoles; Limbic System; Rats; Receptors, Dopamine; Schizophrenia; Schizophrenic Psychology; Substantia Nigra | 1998 |
Implications of brain imaging for the management of schizophrenia.
Topics: Antipsychotic Agents; Brain; Brain Mapping; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Humans; Imidazoles; Indoles; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Serotonin; Risk Factors; Schizophrenia; Tomography, Emission-Computed | 1998 |
Tardive dyskinesia in affective disorders.
Topics: Adult; Affective Disorders, Psychotic; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Controlled Clinical Trials as Topic; Dibenzothiazepines; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Imidazoles; Indoles; Male; Olanzapine; Piperazines; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risk Assessment; Risk Factors; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 1999 |
[New i.e. atypical neuroleptic agents for negative symptoms of schizophrenia: results and methodological problems of evaluation].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Double-Blind Method; Dyskinesia, Drug-Induced; Humans; Imidazoles; Indoles; Neurotransmitter Agents; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Thiazoles | 2000 |
2 trial(s) available for sertindole and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
A double-blind, randomized study comparing the efficacy and safety of sertindole and risperidone in patients with treatment-resistant schizophrenia.
Topics: Adult; Antipsychotic Agents; Double-Blind Method; Drug Resistance; Drug-Related Side Effects and Adverse Reactions; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Imidazoles; Indoles; Male; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2011 |
Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Basal Ganglia Diseases; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Haloperidol; Hospitalization; Humans; Imidazoles; Indoles; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Treatment Outcome | 1997 |
1 other study(ies) available for sertindole and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Chronic olanzapine or sertindole treatment results in reduced oral chewing movements in rats compared to haloperidol.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Dyskinesia, Drug-Induced; Haloperidol; Imidazoles; Indoles; Male; Mastication; Olanzapine; Pirenzepine; Rats; Rats, Sprague-Dawley | 1998 |